Direct Filing of Valsartan Cases into the MDL Granted
Direct Filing of Valsartan Cases into the MDL Granted
Introduction
U.S. District Judge Robert B. Kugler, presiding over all federal valsartan recall lawsuits, allowed the direct filing of new cases into the multidistrict litigation(MDL) established in New Jersey, where all similar claims are consolidated for pretrial proceedings.
Judge Kugler issued a case management order on April 9, in which the process for the direct filing was outlined. There are nearly 50 product liability lawsuits filed against generic valsartan drug manufacturers and distributors, each with similar claims that the blood pressure drug distributed all these years were tainted with cancer-causing impurities, including N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), which are supposedly by-products of the drug's manufacturing process.
Comments
Latest News
Pesticide Shield Bill Faces Long Odds in Missouri Senate
Categories: General
Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.
…Philips Sues CPAP Cleaner SoClean to Share Settlement Costs
Categories: Settlements
Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…
NJ Pharma Settles: Cash, Narcan for Delaware
Categories: Settlements
Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…